ALCON RESEARCH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Assessment of Visual Performance in Patients With Low Levels of Astigmatism

Completed

Conditions: Cataract Extraction
Corneal Astigmatism

Interventions: Other: Visual performance measures

First Posted Date: 2009-02-12

Last Posted Date: 2010-09-28

Lead Sponsor: Alcon Research

Target Recruit Count: 40

Registration Number: NCT00842231

Locations: 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States

Effect on Wound Healing of Vigamox Versus Cravit

Phase 4

Completed

Conditions: Cataract Extraction

Interventions: Drug: Moxifloxacin 0.5% ophthalmic solution (Vigamox)
Drug: Levofloxacin 0.5% ophthalmic solution (Cravit)

First Posted Date: 2009-02-10

Last Posted Date: 2012-07-23

Lead Sponsor: Alcon Research

Target Recruit Count: 79

Registration Number: NCT00840580

A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients

Phase 2

Completed

Conditions: Dry Eye

Interventions: Drug: Hydroxypropyl Guar Galactomannan (HPGG) 0.25% ophthalmic gel
Drug: Hydroxypropyl Guar Galactomannan Vehicle

First Posted Date: 2009-02-10

Last Posted Date: 2014-07-17

Lead Sponsor: Alcon Research

Target Recruit Count: 427

Registration Number: NCT00840268

DuoTrav® Eye Drops As Replacement Therapy Program

Phase 4

Completed

Conditions: Open-angle Glaucoma
Ocular Hypertension

Interventions: Drug: DuoTrav

First Posted Date: 2009-01-26

Last Posted Date: 2012-09-20

Lead Sponsor: Alcon Research

Target Recruit Count: 128

Registration Number: NCT00828906

Locations: 🇨🇳
Contact Alcon for Trial Locations, Bejing, China

Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)

Phase 4

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: Placebo (Tranilast)
Drug: Olopatadine 0.1%
Drug: Tranilast 0.5%
Drug: Placebo (Olopatadine)

First Posted Date: 2009-01-08

Last Posted Date: 2012-06-04

Lead Sponsor: Alcon Research

Target Recruit Count: 50

Registration Number: NCT00818805

Systane Clinical Experience Study

Phase 4

Completed

Conditions: Dry Eye Syndrome

Interventions: Other: Systane

First Posted Date: 2009-01-08

Last Posted Date: 2012-02-02

Lead Sponsor: Alcon Research

Target Recruit Count: 941

Registration Number: NCT00818909

Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery

Phase 4

Completed

Conditions: Epiretinal Membrane

Interventions: Other: BSS
Drug: Nepafenac 0.1%

First Posted Date: 2009-01-08

Last Posted Date: 2015-08-14

Lead Sponsor: Alcon Research

Target Recruit Count: 40

Registration Number: NCT00818844

Locations: 🇺🇸
Dan Miller, Cincinnati, Ohio, United States

Corneal Astigmatism Measurement Study

Completed

Conditions: Astigmatism

First Posted Date: 2009-01-07

Last Posted Date: 2012-04-09

Lead Sponsor: Alcon Research

Target Recruit Count: 50

Registration Number: NCT00818532

Locations: 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Visual Function Evaluation of Bilateral AcrySof ReSTOR Aspheric IOL

Phase 4

Completed

Conditions: Cataracts

Interventions: Device: AcrySof ReSTOR Aspheric IOL

First Posted Date: 2009-01-07

Last Posted Date: 2010-07-30

Lead Sponsor: Alcon Research

Target Recruit Count: 34

Registration Number: NCT00818116

Locations: 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Kynex Versus Refresh Plus Study in Subject With Dry Eye

Phase 4

Completed

Conditions: Dry Eye

Interventions: Other: Carboxymethylcellulose sodium
Other: Sodium Hyaluronate

First Posted Date: 2008-12-17

Last Posted Date: 2012-02-03

Lead Sponsor: Alcon Research

Target Recruit Count: 67

Registration Number: NCT00809198

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy